PATENT CLAIM ANALYSIS

Application Number: 16359878
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-10
Patent Classification: ["514", "505000"]

Abstract:
Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.

Claim (Index 14):
The composition of  claim 1 , further comprising metformin.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 2.19697
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15620542', '14805136', '14805034', '13300059', '13380940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8120464566779917
- 35 USC 102 Novelty (BERT): 0.6067254601279548
- Combined Prediction Score: 0.791514357022988
- Mean Citation Score: 502.032136
- Max Citation Score: 586.8301
- Similarity Product: 475.43399290710687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test